Literature DB >> 26881537

Evaluation of stromal myofibroblasts in oral leukoplakia, oral submucous fibrosis, and oral squamous cell carcinoma--an immunohistochemical study.

Kanupriya Gupta1, Rashmi Metgud, Jatin Gupta.   

Abstract

BACKGROUND: Oral leukoplakia (OL) and oral submucous fibrosis (OSMF) are the main potentially malignant disorders and oral squamous cell carcinoma (OSCC) is the most common malignancy of the oral mucosa. Myofibroblasts (MFs) secrete numerous growth factors and inflammatory mediators that stimulate epithelial cell proliferation and play an important role in tumoral invasion and use a combination of different factors in the course of neoplastic growth and development. Hence the present study was undertaken to evaluate and compare the distribution of MFs using alpha smooth muscle actin (α-SMA) in OL, OSMF, and various histopathological grades OSCC.
MATERIALS AND METHODS: Sixty formalin-fixed paraffin-embedded tissue blocks consisting of histopathologically diagnosed cases of normal mucosa (n = 10), OL (n = 14) hyperkeratosis with various grades of dysplasia, OSMF (n = 11), and OSCC (n = 25) were subjected to immunohistochemistry using α-SMA antibody for detection of MFs.
RESULTS: MFs were not detected in normal oral mucosa. On comparison of frequency of mean scores in OL, OSMF, and OSCC the values were 0.6 ± 0.2 (0-2), 1.2 ± 0.68 (1-2), and 2.6 ± 1.34 (0-4), respectively. The results were statistically significant (P < 0.001).
CONCLUSION: These findings are suggestive of role of MFs with the creation of a permissive environment for tumor invasion in OSCC. Hence the presence of MF is a prognostic marker and evaluation of the frequency in the stroma can be used as therapeutic targets.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26881537     DOI: 10.4103/0973-1482.147700

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  11 in total

Review 1.  Mutual concessions and compromises between stromal cells and cancer cells: driving tumor development and drug resistance.

Authors:  Pritish Nilendu; Sachin C Sarode; Devashree Jahagirdar; Ishita Tandon; Shankargouda Patil; Gargi S Sarode; Jayanta K Pal; Nilesh Kumar Sharma
Journal:  Cell Oncol (Dordr)       Date:  2018-07-19       Impact factor: 6.730

2.  Expression of Matrix Metalloproteinases 7 and 9, Desmin, Alpha-Smooth Muscle Actin and Caldesmon, in Odontogenic Keratocyst Associated with NBCCS, Recurrent and Sporadic Keratocysts.

Authors:  Carla Loreto; Alessandro Polizzi; Veronica Filetti; Giuseppe Pannone; Jean Nunes Dos Santos; Pietro Venezia; Rosalia Leonardi; Gaetano Isola
Journal:  Biomolecules       Date:  2022-06-02

3.  Comparison of expression of myofibroblasts in normal oral mucosa, oral epithelial dysplasia, and oral squamous cell carcinoma using α-SMA and vimentin: An immunohistochemical study.

Authors:  Amani Mahajan; Andleeb Manhas; Tania Aneja; Swati Parhar; Priyanka Kumari; Harkanwal P Singh
Journal:  J Family Med Prim Care       Date:  2020-08-25

4.  Bone mesenchymal stem cells differentiate into myofibroblasts in the tumor microenvironment.

Authors:  Jing Zhang; Dingqi Sun; Qiang Fu; Qingwei Cao; Hui Zhang; Keqin Zhang
Journal:  Oncol Lett       Date:  2016-05-30       Impact factor: 2.967

5.  A primary tumor gene expression signature identifies a crucial role played by tumor stroma myofibroblasts in lymph node involvement in oral squamous cell carcinoma.

Authors:  Tommaso Mazza; Lorenzo Lo Muzio; Gianluigi Mazzoccoli; Stefano Castellana; Massimo Carella; Orazio Palumbo; Cristiana Tiberio; Caterina Fusilli; Daniele Capocefalo; Tommaso Biagini
Journal:  Oncotarget       Date:  2017-09-05

6.  PTEN and α-SMA Expression and Diagnostic Role in Oral Submucous Fibrosis and Oral Squamous Cell Carcinoma with Concomitant Oral Submucous Fibrosis.

Authors:  Roshni Monteiro; Kaveri Hallikeri; Archana Sudhakaran
Journal:  J Oral Maxillofac Res       Date:  2021-03-31

7.  Myofibroblast transdifferentiation is associated with changes in cellular and extracellular vesicle miRNA abundance.

Authors:  Siti Amalina Inche Zainal Abidin; Ian Charles Paterson; Stuart Hunt; Daniel W Lambert; Samuel Higginbotham; Ryan Charles Pink
Journal:  PLoS One       Date:  2021-11-11       Impact factor: 3.240

Review 8.  Microenvironmental regulation of the progression of oral potentially malignant disorders towards malignancy.

Authors:  Ruixue Ai; Yan Tao; Yilong Hao; Lu Jiang; Hongxia Dan; Ning Ji; Xin Zeng; Yu Zhou; Qianming Chen
Journal:  Oncotarget       Date:  2017-08-17

9.  Ki67, CD105, and α-SMA expression supports the transformation relevant dysplastic features in the atrophic epithelium of oral submucous fibrosis.

Authors:  Amol R Gadbail; Minal Chaudhary; Sachin C Sarode; Shailesh Gondivkar; Satyajit A Tekade; Prajakta Zade; Alka Hande; Gargi S Sarode; Shankargouda Patil
Journal:  PLoS One       Date:  2018-07-12       Impact factor: 3.240

10.  A comparative study of the frequency of myofibroblasts and macrophages between the oral and cutaneous squamous cell carcinoma.

Authors:  Samira Mostafazadeh; Paria Emamverdizadeh; Khadijeh Abdal; Sevda Sadat Forghani
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2019
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.